Diphtheria: Corynebacterium diphtheriae is the species responsible for causing diphtheria, a potentially serious respiratory disease. Diphtheria is characterized by the formation of a thick grayish coating in the throat and can lead to difficulty breathing and other complications. Diphtheria is a vaccine-preventable disease, and vaccination programs have been successful in reducing its incidence.
Skin Infections: Some Corynebacterium species, such as Corynebacterium minutissimum, can be associated with skin infections. Erythrasma is one such skin infection caused by this bacterium, characterized by red-brown patches on the skin.
Coryneform Infections: The term "coryneform" is used to describe a group of bacteria, including some Corynebacterium species, that can cause opportunistic infections in humans. These infections may occur in individuals with weakened immune systems, underlying health conditions, or indwelling medical devices.
Normal Microbiota: Many Corynebacterium species are part of the normal microbial flora on human skin and mucous membranes. They contribute to the balance of the microbiota and may have beneficial roles in preventing the colonization of pathogenic bacteria.
Vaccination: The development and widespread use of the diphtheria vaccine have significantly reduced the incidence of diphtheria, highlighting the importance of vaccination in preventing certain Corynebacterium-associated diseases.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
|Statistics||5190 Interactions with Other Bacteria||NCBI||Data Punk||End Products Produced|
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation
|Lab||KM Low||KM Percentile Low||KM High||KM Percentile High||Lab Low||Lab High||Mean||Standard Deviation|
|All||0.001||5.2 %ile||2.601||97.6 %ile||0||3.045||0.263||1.419|
|BiomeSight||0.001||0 %ile||0.491||96.1 %ile||0||1.986||0.139||0.942|
|Ombre/Thryve||0.001||5.8 %ile||0.558||95.8 %ile||0||1.951||0.147||0.921|
|uBiome||0.002||0 %ile||21.243||100 %ile||0||4.713||0.625||2.086|
|Low Boundary||High Boundary||Low Boundary %age||High Boundary %age||Lab Samples|
|Lab||Frequency Seen||Average||Standard Deviation||Sample Count||Lab Samples|
|bugspeak||100 %||0.016 %||%||1.0||1|
|CosmosId||34.211 %||0.005 %||0.008 %||13.0||38|
|AmericanGut||38.889 %||0.322 %||0.368 %||7.0||18|
|BiomeSightRdp||57.778 %||0.01 %||0.024 %||26.0||45|
|es-xenogene||97.143 %||0.035 %||0.035 %||34.0||35|
|SequentiaBiotech||22.222 %||0.187 %||0.19 %||8.0||36|
|Thorne||100 %||2.794 %||7.226 %||55.0||55|
|Tiny||100 %||0.004 %||%||1.0||1|
|uBiome||55.864 %||0.623 %||2.084 %||443.0||793|
|BiomeSight||49.023 %||0.151 %||0.918 %||1305.0||2662|
|custom||32.836 %||1.332 %||2.011 %||22.0||67|
|Medivere||14.286 %||0.001 %||%||1.0||7|
|CerbaLab||66.667 %||0.01 %||0.006 %||2.0||3|
|Thryve||57.034 %||0.137 %||0.81 %||896.0||1571|
And display level must be raised above public.
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC , DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.